🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to enable non-invasive early detection of ovar...
Status
Unknown
Location
The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Start Date
2022-10-01
Trial ID
NCT05693974
The purpose of this project is to examine whether the risk of developing ov...
Status
Unknown
Location
Aarhus University Hospital
Start Date
2011-09
Trial ID
NCT01470235
Patients with a high grade glioma have an increasing overall survival and p...
Status
Withdrawn
Location
Maastricht Radiation Oncology
Start Date
2013-03
Trial ID
NCT01711580
This study will evaluate women who are at increased genetic risk of develop...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2003-07-09
Trial ID
NCT00043472
Lung cancer is the leading cause of cancer death in the United States. Curr...
Status
Completed
Location
University of Minnesota
Start Date
2005-09
Trial ID
NCT00218179
Treatments Being Tested
This pilot study is the first step in the development of an new assay that ...
Status
Completed
Location
BC Cancer Agency
Start Date
2016-02
Trial ID
NCT02622776
Treatments Being Tested
This study tests a multi-component, low cost, message-based communication o...
Status
Completed
Location
Emory University
Start Date
2021-07-24
Trial ID
NCT04927013
This is a combined prospective and retrospective observational study aiming...
Status
Recruiting
Location
Department of Pharmacology, Yonsei University College of Medicine
Start Date
2024-08-21
Trial ID
NCT07035587
Treatments Being Tested
Recruitment for prevention, and early detection among health disparities po...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT02956681
Treatments Being Tested
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-25
Trial ID
NCT05554328